ADVANCED CHOLANGIOCARCINOMA

Clinical trials for ADVANCED CHOLANGIOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED CHOLANGIOCARCINOMA trials appear

Sign up with your email to follow new studies for ADVANCED CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 1

New pill shows promise against rare bile duct cancer in Late-Stage trial

Disease control Not yet recruiting

This study tests a new oral drug, TT-00420, against standard chemotherapy for people with advanced bile duct cancer that has a specific genetic change (FGFR2). The trial includes 138 adults whose cancer worsened after initial treatment. The goal is to see if the new drug can slow…

Matched conditions: ADVANCED CHOLANGIOCARCINOMA

Phase: PHASE3 • Sponsor: TransThera Sciences (Nanjing), Inc. • Aim: Disease control

Last updated May 15, 2026 11:54 UTC

ADVANCED CHOLANGIOCARCINOMA

Get alerted when new ADVANCED CHOLANGIOCARCINOMA trials appear

New pill shows promise against rare bile duct cancer in Late-Stage trial